20230515 lab meeting_照穎 | 賴亮全實驗室

索引

00:00 1.
index 1
00:03 2.
selection of lung metastatic(LM) subpopulations
00:04 3.
Slide 1
01:26 4.
selection of lung metastatic(LM) subpopulations
02:13 5.
LM breast cancer cells exhibited increased cell motility, EMT properties, fast proliferation rate, and less chemosensitivity
03:43 6.
m6A regulated malignancy of LM breast cancer cells
08:38 7.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
08:40 8.
m6A regulated malignancy of LM breast cancer cells
09:08 9.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
14:01 10.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
17:38 11.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
23:36 12.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:37 13.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:56 14.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:57 15.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
24:00 16.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
25:37 17.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
25:42 18.
** after 20230515.pptx
25:47 19.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
30:48 20.
Slide 10
30:49 21.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:45 22.
Slide 10
32:45 23.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:58 24.
Slide 10
32:58 25.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
34:10 26.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
37:36 27.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
37:37 28.
Slide 10
37:37 29.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
38:12 30.
** after 20230515.pptx
38:18 31.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
38:53 32.
Slide 12
38:55 33.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
39:08 34.
Slide 12
39:20 35.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
41:53 36.
m6A reduced RNase activity
41:54 37.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
42:45 38.
Slide 16
42:47 39.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
43:19 40.
Slide 16
43:29 41.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:49 42.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:50 43.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
48:20 44.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
51:09 45.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
52:18 46.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
53:58 47.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
55:23 48.
Slide 22
56:25 49.
** after 20230515.pptx

筆記 (0)

未登入或權限不足!

討論

00:00 1.
index 1
00:03 2.
selection of lung metastatic(LM) subpopulations
00:04 3.
Slide 1
01:26 4.
selection of lung metastatic(LM) subpopulations
02:13 5.
LM breast cancer cells exhibited increased cell motility, EMT properties, fast proliferation rate, and less chemosensitivity
03:43 6.
m6A regulated malignancy of LM breast cancer cells
08:38 7.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
08:40 8.
m6A regulated malignancy of LM breast cancer cells
09:08 9.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
14:01 10.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
17:38 11.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
23:36 12.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:37 13.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:56 14.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:57 15.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
24:00 16.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
25:37 17.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
25:42 18.
** after 20230515.pptx
25:47 19.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
30:48 20.
Slide 10
30:49 21.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:45 22.
Slide 10
32:45 23.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:58 24.
Slide 10
32:58 25.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
34:10 26.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
37:36 27.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
37:37 28.
Slide 10
37:37 29.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
38:12 30.
** after 20230515.pptx
38:18 31.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
38:53 32.
Slide 12
38:55 33.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
39:08 34.
Slide 12
39:20 35.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
41:53 36.
m6A reduced RNase activity
41:54 37.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
42:45 38.
Slide 16
42:47 39.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
43:19 40.
Slide 16
43:29 41.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:49 42.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:50 43.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
48:20 44.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
51:09 45.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
52:18 46.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
53:58 47.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
55:23 48.
Slide 22
56:25 49.
** after 20230515.pptx

分享
- 嵌入網址
- QR code

索引
筆記
討論
全螢幕

20230515 lab meeting_照穎

長度: 57:00, 瀏覽: 355, 最近修訂: 2023-05-16

00:00 1.
index 1
00:03 2.
selection of lung metastatic(LM) subpopulations
00:04 3.
Slide 1
01:26 4.
selection of lung metastatic(LM) subpopulations
02:13 5.
LM breast cancer cells exhibited increased cell motility, EMT properties, fast proliferation rate, and less chemosensitivity
03:43 6.
m6A regulated malignancy of LM breast cancer cells
08:38 7.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
08:40 8.
m6A regulated malignancy of LM breast cancer cells
09:08 9.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
14:01 10.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
17:38 11.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
23:36 12.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:37 13.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:56 14.
KRT7 was involved in m6A-regulated metastasis potential of breast cancer cells
23:57 15.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
24:00 16.
The mRNA stability and translation efficiency of KRT7 increased in LM breast cancer cells
25:37 17.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
25:42 18.
** after 20230515.pptx
25:47 19.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
30:48 20.
Slide 10
30:49 21.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:45 22.
Slide 10
32:45 23.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
32:58 24.
Slide 10
32:58 25.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
34:10 26.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
37:36 27.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
37:37 28.
Slide 10
37:37 29.
METTL3 increased mRNA stability of KRT7 via upregulation of KRT7-AS
38:12 30.
** after 20230515.pptx
38:18 31.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
38:53 32.
Slide 12
38:55 33.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
39:08 34.
Slide 12
39:20 35.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
41:53 36.
m6A reduced RNase activity
41:54 37.
IGF2BP1/HuR complexes increased the stability of KRT7-AS/KRT7 mRNA duplex
42:45 38.
Slide 16
42:47 39.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
43:19 40.
Slide 16
43:29 41.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:49 42.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
46:50 43.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
48:20 44.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
51:09 45.
YTHDF1/eEF-1 was involved in FTO-regulated translation elongation of KRT7 mRNA
52:18 46.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
53:58 47.
The roles of m6A/KRT7/KRT7-AS axis in breast cancer progression
55:23 48.
Slide 22
56:25 49.
** after 20230515.pptx

位置

資料夾名稱

2023

發表人

黃照穎

單位

賴亮全教授

建立

2023-05-15 10:20:39

最近修訂

2023-05-16 16:32:44

長度

57:00